7:40 am Endo Health: Noven announced earlier settlement of Lidoderm patent litigation; agreement allows Noven to launch its generic Lidoderm product on or after March 1, 2015, if the product is approved by the FDA
View todays social media effects on ENDP
View the latest stocks trending across Twitter. Click to view dashboard
See who Endo is hiring next, click here to view
